Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Endra Life Sciences Inc (NDRA)

Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,140
  • Shares Outstanding, K 753
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,510 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta -0.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 26.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.95
  • Number of Estimates 1
  • High Estimate -1.95
  • Low Estimate -1.95
  • Prior Year -9.40
  • Growth Rate Est. (year over year) +79.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.14 +27.82%
on 11/24/25
6.95 -23.86%
on 11/17/25
-1.41 (-21.01%)
since 11/14/25
3-Month
4.14 +27.82%
on 11/24/25
9.85 -46.27%
on 10/13/25
+0.42 (+8.67%)
since 09/15/25
52-Week
2.90 +82.48%
on 05/15/25
11.96 -55.75%
on 07/08/25
+1.02 (+23.93%)
since 12/13/24

Most Recent Stories

More News
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring

NDRA : 5.31 (-3.45%)
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

TAEUS Liver demonstrates strong agreement with the industry’s imaging gold standard, MRI‑PDFF, across the full spectrum of steatotic liver disease and patient BMI

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated...

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

ENDRA is converting static treasury assets into a dynamic rewards engine to support medical innovation

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Company Officially Launches Digital Asset Treasury Strategy Focused on the Highest Conviction Holdings of Arca Investment Management to Enhance Long-Term Shareholder Value

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

Company Also Intends to Appoint Jeff Dorman to Digital Asset Advisory Board

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of T hermo- A coustic E nhanced U ltra S ound (TAEUS ® ...

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced that the company will report financial results for the three months ended...

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Securities

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today the closing of its previously announced underwritten...

NDRA : 5.31 (-3.45%)
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today that it has priced an underwritten public offering...

NDRA : 5.31 (-3.45%)

Business Summary

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

See More

Key Turning Points

3rd Resistance Point 5.97
2nd Resistance Point 5.79
1st Resistance Point 5.64
Last Price 5.31
1st Support Level 5.32
2nd Support Level 5.14
3rd Support Level 4.99

See More

52-Week High 11.96
Fibonacci 61.8% 8.50
Fibonacci 50% 7.43
Fibonacci 38.2% 6.36
Last Price 5.31
52-Week Low 2.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar